BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36268878)

  • 21. Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1.
    Yu J; Lou Y; Hou M; Ma X; Wang L
    J Oral Pathol Med; 2022 Aug; 51(7):630-637. PubMed ID: 35778962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
    Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
    J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CircZNF236 facilitates malignant progression in oral squamous cell carcinoma by sequestering miR-145-5p.
    Lu Q; Che H; Che Y; Hu M
    Clin Transl Oncol; 2023 Jun; 25(6):1690-1701. PubMed ID: 36635458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of circCDR1as drives oral squamous cell carcinoma progression.
    Cui L; Huang C; Zhou D
    Oral Dis; 2023 Apr; 29(3):957-967. PubMed ID: 34817912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-382-5p Promotes Oral Squamous Cell Carcinoma Development and Progression by Negatively Regulating PTEN Expression.
    Xu X; Jin B; Cai L; Zhang Z; Ying Y; Luo J
    J Oral Maxillofac Surg; 2022 Dec; 80(12):2015-2023. PubMed ID: 36162436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome-mediated long noncoding RNA (lncRNA) PART1 suppresses malignant progression of oral squamous cell carcinoma via miR-17-5p/SOCS6 axis.
    Du Y; Shuai Y; Wang H; Li H; Li Y
    Turk J Med Sci; 2023 Jun; 53(3):630-639. PubMed ID: 37476905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.
    Hei N; Chen Y; Peng S; Bao Y; Jin L
    Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircLPAR3 Acts as an Oncogene in Oral Squamous Cell Carcinoma Through Regulating the miR-643/HMGB2 Network.
    Fu Y; Qiu C; Yang Y; Lu J; Qi Y
    Biochem Genet; 2022 Jun; 60(3):882-898. PubMed ID: 34528144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
    Long Y; Li C; Zhu B
    Bioengineered; 2022 May; 13(5):13055-13069. PubMed ID: 35635053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel circ_0004674/miR-139-5p/ZBTB2 regulatory cascade inhibits the development of oral squamous cell carcinoma.
    Qi C; Zhang L; Wang W
    Head Neck; 2024 Jul; 46(7):1671-1682. PubMed ID: 38665011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-30a-5p targets ITGA6 to inhibit oral squamous cell carcinoma progression.
    Zhang G; Wang H; Liu G; Huang J
    Pathol Res Pract; 2024 Jan; 253():155021. PubMed ID: 38103366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA LSINCT5 drives proliferation and migration of oral squamous cell carcinoma through the miRNA-185-5p/ZNF703 axis.
    Wang X; Feng X; Wang H
    J BUON; 2021; 26(1):124-131. PubMed ID: 33721442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of circMYOF inhibits cell growth, metastasis, and glycolysis through miR-145-5p/OTX1 regulatory axis in laryngeal squamous cell carcinoma.
    Li S; Zhang Y; He Z; Xu Q; Li C; Xu B
    Funct Integr Genomics; 2022 Aug; 22(4):1-13. PubMed ID: 35474406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
    Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
    Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verbascoside inhibits oral squamous cell carcinoma cell proliferation, migration, and invasion by the methyltransferase 3-mediated microRNA-31-5p/homeodomain interacting protein kinase 2 axis.
    Huang Y; Wu W; Zhang X
    Arch Oral Biol; 2024 Aug; 164():105979. PubMed ID: 38744201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.